37
8
1
1
カタログ番号 | 製品名 | 別名 | ターゲット |
---|---|---|---|
T4039 | BIBB 515 | Others | |
BIBB 515 is a selective and potent inhibitor of OSC in vivo with an ED50 value of 0.2-0.5 and 0.36-33.3 mg/kg in rats and mice, respectively. 2, 3-Oxidosqualene cyclase (OSC) is an important enzyme in the biosynthesis of... | |||
T64006 | Lipid-lowering agent-1 | ||
Lipid-lowering agent-1 is a potent lipid-lowering agent that significantly inhibits the pharmacological effects of low-density lipoprotein cholesterol (LDLC) and promotes the production of high-density lipoprotein choles... | |||
T10900 | CUDA | PPAR , Epoxide Hydrolase | |
CUDA is an effective soluble cyclohydrolase inhibitor with IC50 of 11.1 nM and 112 nM for mouse sEH and human sEH, respectively. CUDA selectively increases the activity of peroxisome proliferator-activated receptor (PPAR... | |||
T3978 | Linerixibat | GSK2330672,Iinerixibat | HBV |
Linerixibat (GSK2330672) is a highly effective, nonabsorbable ASBT inhibitor (IC50: 42 ± 3 nM). It can lower glucose in an animal model of type 2 diabetes and shows excellent developability properties. | |||
T7133 | Anagliptin | SK-0403 | Proteasome , DPP-4 |
Anagliptin (SK-0403) is a potent Inhibitor of DPP-4(IC50 of 3.8 nM), for the treatment of type 2 diabetes mellitus. | |||
T9010 | IMM-H007 | Others , AMPK | |
IMM-H007 is a novel lipid-lowering agent, increasing abca1 protein expression | |||
T13563 | AZ-1355 | Prostaglandin Receptor | |
AZ-1355 is a novel dibenzoxepine derivative with lipid-lowering properties. | |||
T28882 | Sultosilic acid, piperazine salt | A-585,Mimedran,piperazine-sultosylate,A585,A 585 | |
Sultosilic acid piperazine salt is a drug with lowering lipid activity. It causes significant shortening of the euglobulin lysis time and a significant diminution of platelet adhesiveness, as well as statistically signif... | |||
T28501 | Ragaglitazar | NNC61-0029,NN-622,(-)-DRF-2725,NNC-61-0029,NN 622,NNC 61-0029 | PPAR |
Ragaglitazar(NNC-61-0029) is a potent dual PPARα and PPARγ agonist that has shown potent lipid-lowering and insulin sensitizing effects in animal models.Ragaglitazar can be used to study type 2 diabetes. | |||
T6450 | Clinofibrate | S-8527,Lipoclin | HMG-CoA Reductase , Autophagy |
Clinofibrate (Lipoclin)(IC50 of 0.47 mM), a lipid-lowering agent, inhibits hydroxymethylglutaryl coenzyme A reductase (HMGCR). It is utilized to control high cholesterol and triacylglyceride levels in the blood. | |||
T3625 | Bempedoic acid | ETC1002,ESP-55016,ETC 1002,ETC-1002 | ATP Citrate Lyase , AMPK |
Bempedoic acid (ETC1002) is an orally available, once-daily LDL-C lowering small molecule designed to lower elevated levels of LDL-C and to avoid side effects associated with existing LDL-C lowering therapies. Bempedoic ... | |||
T11386L | Gemcabene | PD-72953 | Others |
T61151 | Beclobrate | Sgd 24774 | Others |
Beclobrate (Sgd 24774) is a novel orally available fibric acid derivative that has shown significant lipid and cholesterol-lowering activity in rodents and may be used in the study of primary hyperlipoproteinemia. | |||
T14933 | Cetaben | Others | |
Cetaben is a PPARα-independent peroxisome proliferator and is a non-fibrate hypolipidemic drug. It potent reduces the concentration of cholesterol and triglycerides. | |||
T4072 | Methyl-β-cyclodextrin | Methyl-beta-cyclodextrin,beta-Cyclodextrin methyl ethers | Others |
Methyl-β-cyclodextrin (Methyl-beta-cyclodextrin) is a macrocyclic compound used as a solubilizer for hydrophobic compounds in biological experiments. Methyl-β-cyclodextrin is also a lipid raft inhibitor with cholesterol-... | |||
T20928 | Febuprol | H33,K-10033,H 33,H-33,NSC 30151 | |
Febuprol, a choleretic drug, stimulates bile secretion. In addition, it also has lipid-lowering (lowering blood lipid) and spasmolytic (anticonvulsant) properties. | |||
T32346 | K 13-004 | K 13004,K13004 | |
K 13-004 is a lipid-lowering agent. | |||
T31720 | Etiroxate, (S)- | ||
Etiroxate, (S)- has a lipid-lowering effect. | |||
T30917 | CI 924 | EINECS 279-174-7,CI-924,CI924 | |
CI 924 is a lipid-lowering drug. CI 924 increased anti-atherosclerotic HDL and decreased VLDL at 600 mg/day. | |||
T30297 | Bay-02752 | ||
BAY-02752 is a lipid lowering agent that has been shown in rats to inhibit the absorption of intestinal cholesterol. | |||
T71734 | Muraglitazar glucuronide | ||
Muraglitazar glucuronide is a Peroxime Proliferator Activated (PPAR) Agonist that has glucose- and lipid-lowering activities. | |||
T10506 | PPAR agonist 1 | PPAR | |
PPAR agonist 1 is an agonist of PPAR α/γ, used for reducing blood glucose, lipid levels, reducing body weight, and lowering cholesterol. | |||
T15710 | Lapaquistat | T-91485 | Others |
Lapaquistat is a cholesterol biosynthesis inhibitor and is the active metabolite of TAK-475. Lapaquistat can reduce statin-induced myotoxicity in lipid-lowering therapy. | |||
T10767 | Cerivastatin sodium | HMG-CoA Reductase | |
Cerivastatin sodium is a synthetic lipid-lowering agent and a highly potent and orally active HMG-CoA reductase inhibitor (Ki: 1.3 nM). It also inhibits the proliferation and invasiveness of MDA-MB-231 cells, mainly by R... | |||
T82434 | Etiroxate | CG-635 | |
Etiroxate (CG-635) is a lipid-lowering agent utilized in hyperlipoproteinemia studies [1]. | |||
T10187 | 6-Raloxifene-β-D-glucopyranoside | Others | |
6-Raloxifene-β-D-glucopyranoside is a benzothiophene glucuronidated at the 6' position. It is a selective and orally active estrogen receptor antagonist. 6-Raloxifene-β-D-glucopyranoside can be used for inhibiting bone l... | |||
T27519 | GW 9578 | GW9578,GW-9578 | PPAR |
GW 9578 is a selective and potent PPARα agonist with potent lipid-lowering activity for the study of psoriasis, arthritis, alopecia, asthma and type I diabetes. | |||
T11386 | Gemcabene calcium | PD-72953 calcium | Others |
T77113 | Ongericimab | ||
Ongericimab (JS002) is a humanized monoclonal antibody targeting PCSK9 with demonstrated lipid-lowering efficacy. It is utilized in the research of hypercholesterolemia and hyperlipidemia [1]. | |||
T13483 | RP 54275 | 2-Octadecyl-1H-indole-5-carboxylic acid | Others |
RP 54275 is a naturally occurring fatty acid derivative, a new cholesterol-lowering compound. It activates the peroxisome proliferator-activated receptor gamma (PPARγ) pathway, which is involved in the regulation of lipi... | |||
T77058 | Lerodalcibep | ||
Lerodalcibep (LIB003), a lipid-lowering agent, consists of a PCSK9-binding domain (adnectin) fused with human serum albumin, forming a recombinant fusion protein. It is utilized in the research of hypercholesterolemia an... | |||
T37255 | 12-methyl Myristic Acid methyl ester | ||
12-methyl Myristic acid methyl ester is a methylated fatty acid methyl ester that has been found in vermicomposts of cattle manure, carica papaya leaves, and cuticular wax of K. africana. It is a volatile compound in lip... | |||
T77144 | Recaticimab | ||
Recaticimab (SHR-1209) is a humanized monoclonal antibody targeting PCSK9 to enhance the degradation of this enzyme. By binding to PCSK9, Recaticimab elevates low-density lipoprotein (LDL) receptor presence on hepatocyte... | |||
T37996 | 17-phenyl trinor Prostaglandin E2 ethyl amide | 17-phenyl trinor Prostaglandin E2 ethyl amide | |
17-phenyl trinor PGE2 ethyl amide is derived from 17-phenyl trinor PGE2, a synthetic analog of PGE2 that acts as an agonist of EP1 and EP3 receptors in mice (Ki = 14 and 3.7 nM, respectively) and EP1, EP3, and EP4 in rat... | |||
T35632 | Pinolenic Acid | ||
Pinolenic acid is a polyunsaturated fatty acid found in Korean pine (Pinus orientalis) and maritime pine (Pinus pinaster) seed oils. Both oils have been found to have lipid-lowering properties. A diet containing maritime... | |||
T82900 | Bemfivastatin hemicalcium | PPD 10558 hemicalcium | |
Bemfivastatin hemicalcium (PPD 10558), an orally active HMG-CoA reductase inhibitor, serves as a lipid-lowering agent. It amplifies liver extract activity and exhibits no-observed adverse effect levels (NOAEL) at dosages... | |||
T35633 | Pinolenic Acid ethyl ester | ||
Pinolenic acid is a polyunsaturated fatty acid found in Korean pine (Pinus orientalis) and maritime pine (Pinus pinaster) seed oils. Both oils have been found to have lipid-lowering properties. A diet containing maritime... |
カタログ番号 | 製品名 | 別名 | ターゲット |
---|---|---|---|
T2824 | Pedunculoside | Others , Fatty Acid Synthase | |
Pedunculoside is extracted from Ilex rotunda Thunb. | |||
T0683 | Mevastatin | Compactin,ML236B | Apoptosis , Antibacterial , Antibiotic , HMG-CoA Reductase , Autophagy , Lipid |
Mevastatin (ML236B) is an HMG-CoA reductase inhibitor that was initially isolated from the mold Pythium ultimum. Mevastatin was the first statin to enter clinical trials. | |||
T1035 | Hesperidin | Hesperetin 7-rutinoside,Cirantin | Apoptosis , Reactive Oxygen Species , Endogenous Metabolite , Autophagy |
Hesperidin (Cirantin) is a flavanone glycoside found in citrus fruits with antioxidant, anti-inflammatory, anti-carcinogenic, and antihypertensive and lipid-lowering activity. | |||
TN1644 | Flavanomarein | Others | |
Flavanomarein demonstrates potent antioxidative property, including free radical scavenging activity, inhibition of lipid peroxidation, as well as lipid-lowering effects in human HepG2 hepatocellular carcinoma cells trea... | |||
T0595 | Naringin | Naringoside | Mitophagy , P450 , Endogenous Metabolite , Autophagy |
Naringin (Naringoside), a flavanone glycoside, exerts various of pharmacological effects such as blood lipid lowering, antioxidant activity, anticancer activity, and inhibition of cytochrome P450 enzymes. | |||
T0539 | Dihydrocaffeic acid | Hydrocaffeic acid | Antioxidant , p38 MAPK , Endogenous Metabolite |
Dihydrocaffeic acid (Hydrocaffeic acid), a metabolite of chlorogenic acid, is a well-known anti-oxidant component, has anti-oxidative, anti-Alzheimer's, neuroprotective, arousal, and lipid-lowering effects. | |||
T6S0221 | Eriocitrin | eriodictyol 7-rutinoside,Eriodictyol-7-O-Rutinoside,Eriodictioside,Eriodictyol glycoside | Apoptosis , Carbonic Anhydrase |
1. Eriocitrin (Eriodictyol-7-O-Rutinoside) is powerful antioxidative flavonoid; (1) Prevents oxidative damages caused by acute exercise-induced oxidative stress.(2) Lipid-lowering effects in a rat model of high-fat diet.... | |||
TN1998 | Notoginsenoside T5 | MMP | |
Total panax notoginsenosides (TPNS) are the main active ingredients in San-Chi, the root of(Burk) F.H. Chen, which belongs to the Araliaceae family and has been used in traditional Chinese medicine to treat atheroscleros... |
カタログ番号 | 製品名 | Species | Expression System |
---|---|---|---|
TMPY-06810 | SFTPB Protein, Human, Recombinant (His) | Human | CHO Cells |
Pulmonary surfactant-associated protein B, also known as SFTPB and SP-B, contains one saposin A-type domain and three saposin B-type domains. SP-B is produced primarily by alveolar type II cells (AEC2) but also by noncil... |
カタログ番号 | 製品名 | ||
---|---|---|---|
L5400 | Anti-Cardiovascular Disease Compound Library | 1408 compounds | |
A unique collection of 1408 cardiovascular diseases related compounds for high throughput screening (HTS) and high content screening (HCS); |